US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

13.98

+0.99007.62%

Post-market: 13.980.00000.00%18:43 EST

Volume:933.90K

Turnover:12.92M

Market Cap:1.54B

PE:-7.88

High:14.08

Open:13.35

Low:13.27

Close:12.99

52wk High:17.49

52wk Low:2.60

Shares:109.82M

Float Shares:65.45M

Volume Ratio:0.71

T/O Rate:1.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7742

EPS(LYR):-4.4281

ROE:-56.52%

ROA:-39.44%

PB:4.62

PE(LYR):-3.16

Loading ...

Overview Company News Filings

Amylyx Co-CEO Justin B. Klee Reports Sale of Common Shares

Amylyx Co-CEO Joshua B. Cohen Reports Disposal of Common Shares

Amylyx Pharmaceuticals (AMLX) Valuation Check After AMX0318 Rare Disease Pipeline Update

Simply Wall St.

Amylyx Co-CEO Justin Klee Reports Sale of Common Shares

Amylyx Pharmaceuticals Nominates AMX0318 as Candidate to Treat Post-Bariatric Hypoglycemia

MT Newswires Live

Amylyx selects AMX0318 as development candidate for PBH

Amylyx Pharmaceuticals Advances AMX0318 as Long-Acting GLP-1 Receptor Antagonist for Rare Diseases

Amylyx Pharmaceuticals Announces Nomination of Amx0318 as a Novel, Long-Acting Glp-1 Receptor Antagonist Development Candidate, Identified in Collaboration With Gubra a/S

THOMSON REUTERS

Amylyx Pharmaceuticals Inc - Gubra to Receive Over $50 Mln in Milestones and Royalties

THOMSON REUTERS

Assessing Amylyx Pharmaceuticals (AMLX) Valuation After Insider Buying And AMX0114 Trial Progress

Simply Wall St.

Director Karen Firestone Acquires Common Shares of Amylyx Pharmaceuticals Inc

Is Amylyx Pharmaceuticals (AMLX) Overvalued After Its 250% Year‑to‑Date Share Price Surge?

Simply Wall St.

BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companies

BUZZ-Amylyx rises after promising early-stage trial for ALS drug

BRIEF-Amylyx Pharmaceuticals Announces New Safety And Tolerability Cohort 1 Data Of Amx0114

Amylyx Reports Positive Early Safety Data for AMX0114 in ALS Phase 1 LUMINA Trial

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of Amx0114 in ALS From First-in-Human Lumina Trial

THOMSON REUTERS

Amylyx Pharmaceuticals Inc - Amx0114 Well-Tolerated With No Serious Adverse Events

THOMSON REUTERS

Amylyx Pharmaceuticals Chief Medical Officer Camille L. Bedrosian Reports Disposal of Common Shares

Amylyx Pharmaceuticals Q3 EPS USD -0.37 Vs. IBES Estimate USD -0.47

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AMLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":13.98,"timestamp":1770411600000,"preClose":12.99,"halted":0,"volume":933902,"hourTrading":{"tag":"盘后","latestPrice":13.98,"preClose":13.98,"latestTime":"18:43 EST","volume":28730,"amount":401650.3085,"timestamp":1770421384374,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07621247113163974,"floatShares":65449399,"shares":109819569,"eps":-1.774191,"marketStatus":"Market Closed","change":0.99,"latestTime":"02-06 16:00:00 EST","open":13.35,"high":14.08,"low":13.27,"amount":12920588.336316,"amplitude":0.062356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.774191,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":12.99,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":13.5,"preClose":12.99,"latestTime":"09:16 EST","volume":1,"amount":13.5,"timestamp":1770387370374,"change":0.51,"changeRate":0.039261,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":13.98,"preClose":13.98,"latestTime":"18:43 EST","volume":28730,"amount":401650.3085,"timestamp":1770421384374,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7107766880128209,"impliedVol":0.3942,"impliedVolPercentile":0.2231},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","floatShares":65449399,"roa":"-39.44%","roe":"-56.52%","lyrEps":-4.428139,"volumeRatio":0.7107766880128209,"shares":109819569,"dividePrice":0,"high":14.08,"amplitude":0.062356,"preClose":12.99,"low":13.27,"week52Low":2.6,"pbRate":"4.62","psRate":"-2308.69","week52High":17.49,"institutionHeld":0,"latestPrice":13.98,"eps":-1.774191,"divideRate":0,"volume":933902,"delay":0,"ttmEps":-1.774191,"open":13.35,"prevYearClose":12.08,"prevWeekClose":14.29,"prevMonthClose":14.29,"prevQuarterClose":12.08,"fiveDayClose":14.29,"twentyDayClose":11.83,"sixtyDayClose":12.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"AMLX","fiscalQuarterEnding":"2025/09","expectedEps":-0.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-08-07","symbol":"AMLX","fiscalQuarterEnding":"2025/06","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-05-08","symbol":"AMLX","fiscalQuarterEnding":"2025/03","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-03-04","symbol":"AMLX","fiscalQuarterEnding":"2024/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-11-07","symbol":"AMLX","fiscalQuarterEnding":"2024/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.53}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":10,"updateTime":1761541200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMLX","date":"2026-02-05","current":-7.879648,"percent":0.341,"low":-27.24786,"twenty":-12.695651,"median":-7.771731,"eighty":-1.034357,"high":660.566108,"avg":30.453066,"sd":139.733386,"marketCap":1524295617},"quantilePoints":[{"date":"2022-01-07","current":-14.965618,"twenty":-15.735846,"median":-15.735846,"eighty":-15.273709,"marketCap":1020340854},{"date":"2022-01-14","current":-17.069252,"twenty":-16.953304,"median":-16.183076,"eighty":-15.273709,"marketCap":1163764527},{"date":"2022-01-21","current":-15.338309,"twenty":-17.016247,"median":-16.328011,"eighty":-15.417816,"marketCap":1045750560},{"date":"2022-01-28","current":-16.564048,"twenty":-16.799258,"median":-16.025717,"eighty":-15.619898,"marketCap":1129320260},{"date":"2022-02-04","current":-18.651119,"twenty":-18.372842,"median":-16.597176,"eighty":-15.696092,"marketCap":1271614612},{"date":"2022-02-11","current":-15.942897,"twenty":-17.579425,"median":-16.564048,"eighty":-15.735846,"marketCap":1086970750},{"date":"2022-02-18","current":-21.939082,"twenty":-18.462288,"median":-16.667574,"eighty":-15.754066,"marketCap":1495784684},{"date":"2022-02-25","current":-25.657711,"twenty":-19.073502,"median":-16.791804,"eighty":-15.826948,"marketCap":1749317082},{"date":"2022-03-04","current":-22.684464,"twenty":-21.939082,"median":-17.052688,"eighty":-15.942897,"marketCap":1546604096},{"date":"2022-03-11","current":-21.541545,"twenty":-22.684464,"median":-17.512341,"eighty":-16.025717,"marketCap":1468680998},{"date":"2022-03-18","current":-18.841605,"twenty":-22.361465,"median":-18.560016,"eighty":-16.24105,"marketCap":1284601795},{"date":"2022-03-25","current":-20.705061,"twenty":-21.939082,"median":-18.237018,"eighty":-16.28246,"marketCap":1411650325},{"date":"2022-04-01","current":-8.475859,"twenty":-21.905954,"median":-17.624148,"eighty":-15.826948,"marketCap":745290715},{"date":"2022-04-08","current":-8.982567,"twenty":-21.541545,"median":-17.06097,"eighty":-15.603334,"marketCap":789846138},{"date":"2022-04-14","current":-7.771731,"twenty":-21.528294,"median":-16.965727,"eighty":-13.72994,"marketCap":683376036},{"date":"2022-04-22","current":-6.560894,"twenty":-20.869045,"median":-16.804227,"eighty":-9.310283,"marketCap":576905934},{"date":"2022-04-29","current":-5.922572,"twenty":-20.605676,"median":-16.667574,"eighty":-8.660117,"marketCap":520777674},{"date":"2022-05-06","current":-5.034186,"twenty":-19.593613,"median":-16.564048,"eighty":-7.877021,"marketCap":442661022},{"date":"2022-05-13","current":-4.079021,"twenty":-19.267301,"median":-16.261755,"eighty":-7.076815,"marketCap":494605759},{"date":"2022-05-20","current":-4.199702,"twenty":-19.20767,"median":-15.942897,"eighty":-6.639861,"marketCap":509239066},{"date":"2022-05-27","current":-4.23832,"twenty":-19.098348,"median":-15.735846,"eighty":-6.288455,"marketCap":513921724},{"date":"2022-06-03","current":-5.961646,"twenty":-19.02381,"median":-15.644744,"eighty":-5.98953,"marketCap":722885341},{"date":"2022-06-10","current":-6.531261,"twenty":-18.965835,"median":-14.965618,"eighty":-5.946016,"marketCap":791954547},{"date":"2022-06-17","current":-8.606975,"twenty":-18.884671,"median":-12.812292,"eighty":-5.98953,"marketCap":1043647419},{"date":"2022-06-24","current":-9.031773,"twenty":-18.838292,"median":-9.572716,"eighty":-6.047604,"marketCap":1095156658},{"date":"2022-07-01","current":-9.398643,"twenty":-18.760441,"median":-9.500016,"eighty":-6.16474,"marketCap":1139641910},{"date":"2022-07-08","current":-10.721308,"twenty":-18.632898,"median":-9.557942,"eighty":-6.256367,"marketCap":1300022949},{"date":"2022-07-15","current":-9.89585,"twenty":-18.528544,"median":-9.681037,"eighty":-6.279867,"marketCap":1199931133},{"date":"2022-07-22","current":-10.644072,"twenty":-18.336402,"median":-9.891022,"eighty":-6.326623,"marketCap":1290657633},{"date":"2022-07-29","current":-13.028731,"twenty":-18.053157,"median":-10.004462,"eighty":-6.460206,"marketCap":1579811769},{"date":"2022-08-05","current":-12.029491,"twenty":-17.90905,"median":-10.243411,"eighty":-6.531923,"marketCap":1458647991},{"date":"2022-08-12","current":-9.562145,"twenty":-17.579425,"median":-10.400296,"eighty":-6.536805,"marketCap":1466842643},{"date":"2022-08-19","current":-9.485831,"twenty":-17.334277,"median":-10.06963,"eighty":-6.548772,"marketCap":1455135998},{"date":"2022-08-26","current":-10.039108,"twenty":-17.065939,"median":-9.989202,"eighty":-6.580636,"marketCap":1540009176},{"date":"2022-09-02","current":-6.898786,"twenty":-17.03778,"median":-9.89585,"eighty":-6.660919,"marketCap":1058280726},{"date":"2022-09-09","current":-11.401313,"twenty":-16.97815,"median":-9.89585,"eighty":-6.659603,"marketCap":1748972792},{"date":"2022-09-16","current":-11.210528,"twenty":-16.953304,"median":-9.989202,"eighty":-6.666184,"marketCap":1719706179},{"date":"2022-09-23","current":-10.634357,"twenty":-16.878765,"median":-10.096343,"eighty":-6.830104,"marketCap":1631321008},{"date":"2022-09-30","current":-10.741197,"twenty":-16.804227,"median":-10.278624,"eighty":-6.898786,"marketCap":1647710311},{"date":"2022-10-07","current":-13.802176,"twenty":-16.779381,"median":-10.619936,"eighty":-6.916248,"marketCap":2117267640},{"date":"2022-10-14","current":-14.91268,"twenty":-16.704843,"median":-10.68269,"eighty":-6.955732,"marketCap":2287620052},{"date":"2022-10-21","current":-15.663927,"twenty":-16.630305,"median":-10.741197,"eighty":-7.071912,"marketCap":2402862058},{"date":"2022-10-28","current":-15.698467,"twenty":-16.564048,"median":-10.820266,"eighty":-7.107086,"marketCap":2408160541},{"date":"2022-11-04","current":-14.839283,"twenty":-16.564048,"median":-11.050268,"eighty":-7.166312,"marketCap":2276360776},{"date":"2022-11-11","current":-12.241999,"twenty":-16.414972,"median":-11.147569,"eighty":-7.617391,"marketCap":2252711412},{"date":"2022-11-18","current":-12.598457,"twenty":-16.350411,"median":-11.290658,"eighty":-7.771731,"marketCap":2318305067},{"date":"2022-11-25","current":-13.952278,"twenty":-16.29605,"median":-11.35934,"eighty":-7.771731,"marketCap":2567428447},{"date":"2022-12-02","current":-14.125106,"twenty":-16.249332,"median":-11.460456,"eighty":-7.806593,"marketCap":2599231432},{"date":"2022-12-09","current":-12.836096,"twenty":-16.1662,"median":-11.775251,"eighty":-7.885736,"marketCap":2362034171},{"date":"2022-12-16","current":-12.843297,"twenty":-16.050071,"median":-11.935471,"eighty":-8.033728,"marketCap":2363359296},{"date":"2022-12-23","current":-12.803691,"twenty":-15.960795,"median":-12.029491,"eighty":-8.236016,"marketCap":2356071112},{"date":"2022-12-30","current":-13.304172,"twenty":-15.943564,"median":-12.241999,"eighty":-8.385046,"marketCap":2448167255},{"date":"2023-01-06","current":-13.318575,"twenty":-15.896517,"median":-12.362571,"eighty":-8.462395,"marketCap":2450817503},{"date":"2023-01-13","current":-13.498604,"twenty":-15.790507,"median":-12.391845,"eighty":-8.473431,"marketCap":2483945612},{"date":"2023-01-20","current":-13.275368,"twenty":-15.735846,"median":-12.443631,"eighty":-8.502082,"marketCap":2442866757},{"date":"2023-01-27","current":-14.737206,"twenty":-15.72837,"median":-12.465235,"eighty":-8.626816,"marketCap":2711867002},{"date":"2023-02-03","current":-13.192554,"twenty":-15.696004,"median":-12.546391,"eighty":-8.713372,"marketCap":2427627827},{"date":"2023-02-10","current":-12.278005,"twenty":-15.681709,"median":-12.523129,"eighty":-8.748896,"marketCap":2259337033},{"date":"2023-02-17","current":-13.368983,"twenty":-15.658746,"median":-12.575053,"eighty":-8.817175,"marketCap":2460093374},{"date":"2023-02-24","current":-12.425629,"twenty":-15.638022,"median":-12.582254,"eighty":-8.982159,"marketCap":2286502083},{"date":"2023-03-03","current":-12.321212,"twenty":-15.603334,"median":-12.537247,"eighty":-8.982567,"marketCap":2267287779},{"date":"2023-03-10","current":-11.039402,"twenty":-15.534402,"median":-12.530188,"eighty":-9.031773,"marketCap":2031415643},{"date":"2023-03-17","current":-10.186966,"twenty":-15.504179,"median":-12.49404,"eighty":-9.054954,"marketCap":2020839392},{"date":"2023-03-24","current":-9.665679,"twenty":-15.486909,"median":-12.456774,"eighty":-9.147083,"marketCap":1917428991},{"date":"2023-03-31","current":-9.867467,"twenty":-15.435099,"median":-12.43283,"eighty":-9.169128,"marketCap":1957458823},{"date":"2023-04-06","current":-9.352906,"twenty":-15.421283,"median":-12.415671,"eighty":-9.271642,"marketCap":1855382750},{"date":"2023-04-14","current":-10.284497,"twenty":-15.404013,"median":-12.363817,"eighty":-9.314874,"marketCap":2040187145},{"date":"2023-04-21","current":-10.371939,"twenty":-15.352203,"median":-12.317611,"eighty":-9.344721,"marketCap":2057533405},{"date":"2023-04-28","current":-9.540583,"twenty":-15.33867,"median":-12.281606,"eighty":-9.352541,"marketCap":1892613220},{"date":"2023-05-05","current":-9.381574,"twenty":-15.156691,"median":-12.115978,"eighty":-9.37584,"marketCap":1861069667},{"date":"2023-05-12","current":-12.985377,"twenty":-14.994752,"median":-12.108777,"eighty":-9.395229,"marketCap":1934223866},{"date":"2023-05-19","current":-12.108956,"twenty":-14.947446,"median":-12.115978,"eighty":-9.401237,"marketCap":1803677398},{"date":"2023-05-26","current":-11.860914,"twenty":-14.918725,"median":-12.116976,"eighty":-9.404582,"marketCap":1766730562},{"date":"2023-06-02","current":-11.026591,"twenty":-14.881594,"median":-12.108866,"eighty":-9.409977,"marketCap":1642454838},{"date":"2023-06-09","current":-11.838365,"twenty":-14.847918,"median":-12.041308,"eighty":-9.445302,"marketCap":1763371758},{"date":"2023-06-16","current":-11.166396,"twenty":-14.778037,"median":-12.006124,"eighty":-9.4782,"marketCap":1663279418},{"date":"2023-06-23","current":-11.175416,"twenty":-14.689959,"median":-11.960384,"eighty":-9.490139,"marketCap":1664622940},{"date":"2023-06-30","current":-9.461672,"twenty":-14.615348,"median":-11.875318,"eighty":-9.487985,"marketCap":1409353885},{"date":"2023-07-07","current":-9.276768,"twenty":-14.600384,"median":-11.818255,"eighty":-9.461672,"marketCap":1381811698},{"date":"2023-07-14","current":-10.372662,"twenty":-14.560777,"median":-11.775251,"eighty":-9.461672,"marketCap":1545049541},{"date":"2023-07-21","current":-10.106581,"twenty":-14.525026,"median":-11.523392,"eighty":-9.466753,"marketCap":1505415661},{"date":"2023-07-28","current":-10.038933,"twenty":-14.511152,"median":-11.468324,"eighty":-9.484221,"marketCap":1495339251},{"date":"2023-08-04","current":-10.169719,"twenty":-14.445559,"median":-11.399203,"eighty":-9.485831,"marketCap":1514820310},{"date":"2023-08-11","current":-19.589727,"twenty":-14.445559,"median":-11.396399,"eighty":-9.496602,"marketCap":1426386819},{"date":"2023-08-18","current":-18.701388,"twenty":-14.600384,"median":-11.401111,"eighty":-9.500016,"marketCap":1361704186},{"date":"2023-08-25","current":-20.107925,"twenty":-14.86087,"median":-11.504635,"eighty":-9.535435,"marketCap":1464118355},{"date":"2023-09-01","current":-19.950615,"twenty":-15.111286,"median":-11.536747,"eighty":-9.540583,"marketCap":1452664139},{"date":"2023-09-08","current":-19.321375,"twenty":-15.404013,"median":-11.782004,"eighty":-9.55447,"marketCap":1406847273},{"date":"2023-09-15","current":-18.146176,"twenty":-15.510224,"median":-11.838365,"eighty":-9.561304,"marketCap":1321277540},{"date":"2023-09-22","current":-16.730386,"twenty":-15.668372,"median":-11.914636,"eighty":-9.580399,"marketCap":1218189593},{"date":"2023-09-29","current":-17.119034,"twenty":-15.754066,"median":-11.982756,"eighty":-9.586985,"marketCap":1246488245},{"date":"2023-10-06","current":-16.443526,"twenty":-16.050071,"median":-12.0354,"eighty":-9.604096,"marketCap":1197302493},{"date":"2023-10-13","current":-16.29547,"twenty":-16.249332,"median":-12.108777,"eighty":-9.611049,"marketCap":1186522054},{"date":"2023-10-20","current":-15.314596,"twenty":-16.285062,"median":-12.116976,"eighty":-9.618907,"marketCap":1115101646},{"date":"2023-10-27","current":-14.759384,"twenty":-16.274178,"median":-12.163074,"eighty":-9.620949,"marketCap":1074675000},{"date":"2023-11-03","current":-16.674865,"twenty":-16.274178,"median":-12.257781,"eighty":-9.623732,"marketCap":1214146928},{"date":"2023-11-10","current":450.85384,"twenty":-16.339423,"median":-12.267893,"eighty":-9.620949,"marketCap":827767651},{"date":"2023-11-17","current":446.073172,"twenty":-16.292868,"median":-12.208173,"eighty":-9.585468,"marketCap":818990343},{"date":"2023-11-24","current":484.318522,"twenty":-16.28246,"median":-12.115978,"eighty":-9.540583,"marketCap":889208807},{"date":"2023-12-01","current":520.725154,"twenty":-16.24105,"median":-12.108777,"eighty":-9.485831,"marketCap":956051382},{"date":"2023-12-08","current":522.931616,"twenty":-16.175174,"median":-12.029491,"eighty":-9.457162,"marketCap":960102447},{"date":"2023-12-15","current":542.054291,"twenty":-16.147488,"median":-11.981987,"eighty":-9.401886,"marketCap":995211679},{"date":"2023-12-22","current":513.002535,"twenty":-16.036371,"median":-11.889723,"eighty":-9.351083,"marketCap":941872654},{"date":"2023-12-29","current":542.422035,"twenty":-16.030819,"median":-11.849639,"eighty":-9.28907,"marketCap":995886856},{"date":"2024-01-05","current":611.925604,"twenty":-16.026838,"median":-11.798146,"eighty":-9.172617,"marketCap":1123495409},{"date":"2024-01-12","current":596.480367,"twenty":-16.009487,"median":-11.66078,"eighty":-8.992408,"marketCap":1095137953},{"date":"2024-01-19","current":547.202704,"twenty":-15.944565,"median":-11.523392,"eighty":-8.742138,"marketCap":1004664164},{"date":"2024-01-26","current":565.222148,"twenty":-15.942897,"median":-11.468324,"eighty":-8.471813,"marketCap":1037747863},{"date":"2024-02-02","current":609.351398,"twenty":-15.826948,"median":-11.399203,"eighty":-7.903343,"marketCap":1118769167},{"date":"2024-02-09","current":568.531842,"twenty":-15.82354,"median":-11.35934,"eighty":-7.617391,"marketCap":1043824461},{"date":"2024-02-16","current":565.589892,"twenty":-15.749512,"median":-11.333465,"eighty":-6.955732,"marketCap":1038423041},{"date":"2024-02-23","current":25.505487,"twenty":-15.738579,"median":-11.295413,"eighty":-6.79732,"marketCap":1256680857},{"date":"2024-03-01","current":25.931954,"twenty":-15.735846,"median":-11.210528,"eighty":-6.545379,"marketCap":1277693320},{"date":"2024-03-08","current":26.097038,"twenty":-15.705943,"median":-11.186691,"eighty":-6.413487,"marketCap":1285827176},{"date":"2024-03-15","current":4.360971,"twenty":-15.688617,"median":-11.153292,"eighty":-6.087088,"marketCap":214869380},{"date":"2024-03-22","current":3.94826,"twenty":-15.668372,"median":-11.128797,"eighty":-5.859309,"marketCap":194534738},{"date":"2024-03-28","current":3.962017,"twenty":-15.648384,"median":-11.044835,"eighty":-4.906998,"marketCap":195212560},{"date":"2024-04-05","current":3.590578,"twenty":-15.617209,"median":-11.017571,"eighty":-4.329072,"marketCap":176911382},{"date":"2024-04-12","current":3.150354,"twenty":-15.591102,"median":-10.839424,"eighty":-4.211287,"marketCap":155221098},{"date":"2024-04-19","current":2.723887,"twenty":-15.55382,"median":-10.788969,"eighty":-4.079021,"marketCap":134208635},{"date":"2024-04-26","current":2.456825,"twenty":-15.516268,"median":-10.74692,"eighty":-3.715047,"marketCap":121050233},{"date":"2024-05-03","current":2.760478,"twenty":-15.493817,"median":-10.721308,"eighty":2.527963,"marketCap":136011498},{"date":"2024-05-10","current":-1.807875,"twenty":-15.455823,"median":-10.639214,"eighty":2.639017,"marketCap":128530865},{"date":"2024-05-17","current":-1.750482,"twenty":-15.424737,"median":-10.575606,"eighty":2.605891,"marketCap":124450520},{"date":"2024-05-24","current":-1.702655,"twenty":-15.407467,"median":-10.55061,"eighty":2.581476,"marketCap":121050233},{"date":"2024-05-31","current":-1.607,"twenty":-15.376381,"median":-10.462744,"eighty":2.542829,"marketCap":114249658},{"date":"2024-06-07","current":-1.683524,"twenty":-15.339392,"median":-10.375302,"eighty":2.481669,"marketCap":119690118},{"date":"2024-06-14","current":-1.607,"twenty":-15.333566,"median":-10.371939,"eighty":2.451304,"marketCap":114249658},{"date":"2024-06-21","current":-1.578303,"twenty":-15.314596,"median":-10.345603,"eighty":2.42922,"marketCap":112209485},{"date":"2024-06-28","current":-1.846137,"twenty":-15.233272,"median":-10.336583,"eighty":0.837689,"marketCap":131251095},{"date":"2024-07-05","current":-1.693089,"twenty":-15.107531,"median":-10.295995,"eighty":-1.553433,"marketCap":120370175},{"date":"2024-07-12","current":-2.180928,"twenty":-15.067132,"median":-10.277956,"eighty":-1.570651,"marketCap":155053107},{"date":"2024-07-15","current":-2.066143,"twenty":-15.041754,"median":-10.273446,"eighty":-1.572564,"marketCap":146892417},{"date":"2024-08-02","current":-1.980053,"twenty":-15.016375,"median":-10.2672,"eighty":-1.574477,"marketCap":140771900},{"date":"2024-08-09","current":-0.738827,"twenty":-14.951989,"median":-10.237413,"eighty":-1.574477,"marketCap":122548442},{"date":"2024-08-16","current":-0.886592,"twenty":-14.924769,"median":-10.186966,"eighty":-0.851292,"marketCap":147058130},{"date":"2024-08-23","current":-0.91122,"twenty":-14.881594,"median":-10.176877,"eighty":-0.87551,"marketCap":151143078},{"date":"2024-08-30","current":-0.870174,"twenty":-14.847918,"median":-10.167464,"eighty":-0.872636,"marketCap":144334832},{"date":"2024-09-06","current":-0.90301,"twenty":-14.807323,"median":-10.14717,"eighty":-0.871816,"marketCap":149781429},{"date":"2024-09-13","current":-1.022044,"twenty":-14.750513,"median":-10.111091,"eighty":-0.874278,"marketCap":169525345},{"date":"2024-09-20","current":-1.182123,"twenty":-14.689959,"median":-10.097576,"eighty":-0.875099,"marketCap":196077507},{"date":"2024-09-27","current":-1.31347,"twenty":-14.611607,"median":-10.070502,"eighty":-0.880435,"marketCap":217863897},{"date":"2024-10-04","current":-1.20675,"twenty":-14.591806,"median":-10.05255,"eighty":-0.886592,"marketCap":200162455},{"date":"2024-10-11","current":-1.420189,"twenty":-14.573388,"median":-9.984815,"eighty":-0.893159,"marketCap":235565339},{"date":"2024-10-18","current":-1.609,"twenty":-14.563346,"median":-9.930486,"eighty":-0.90301,"marketCap":266883274},{"date":"2024-10-25","current":-2.01125,"twenty":-14.546477,"median":-9.907825,"eighty":-0.904652,"marketCap":333604093},{"date":"2024-10-31","current":-2.16312,"twenty":-14.522251,"median":-9.891022,"eighty":-0.907936,"marketCap":358794606},{"date":"2024-11-08","current":-1.71606,"twenty":-14.498033,"median":-9.867467,"eighty":-0.91122,"marketCap":445259340},{"date":"2024-11-15","current":-1.317221,"twenty":-14.412048,"median":-9.847288,"eighty":-0.912041,"marketCap":341773989},{"date":"2024-11-22","current":-1.361828,"twenty":-14.258948,"median":-9.820895,"eighty":-0.917787,"marketCap":353348008},{"date":"2024-11-29","current":-1.453666,"twenty":-14.182716,"median":-9.792708,"eighty":-0.927638,"marketCap":377176872},{"date":"2024-12-06","current":-1.304101,"twenty":-14.161433,"median":-9.786381,"eighty":-0.927638,"marketCap":338369865},{"date":"2024-12-13","current":-1.15716,"twenty":-14.135908,"median":-9.753975,"eighty":-0.972788,"marketCap":300243683},{"date":"2024-12-20","current":-1.039082,"twenty":-14.125106,"median":-9.730036,"eighty":-1.022044,"marketCap":269606573},{"date":"2024-12-27","current":-1.067946,"twenty":-14.113584,"median":-9.665679,"eighty":-1.031477,"marketCap":277095644},{"date":"2025-01-03","current":-1.025963,"twenty":-14.015648,"median":-9.642275,"eighty":-1.012318,"marketCap":266202449},{"date":"2025-01-10","current":-0.989228,"twenty":-13.942196,"median":-9.632047,"eighty":-1.007595,"marketCap":256670904},{"date":"2025-01-17","current":-0.918381,"twenty":-13.90403,"median":-9.621327,"eighty":-0.945698,"marketCap":238288638},{"date":"2025-01-24","current":-0.934125,"twenty":-13.865081,"median":-9.609998,"eighty":-0.927638,"marketCap":242373586},{"date":"2025-01-31","current":-0.921005,"twenty":-13.841127,"median":-9.584963,"eighty":-0.918381,"marketCap":238969462},{"date":"2025-02-07","current":-0.98398,"twenty":-13.8128,"median":-9.549263,"eighty":-0.918381,"marketCap":255309255},{"date":"2025-02-14","current":-0.941996,"twenty":-13.770986,"median":-9.500016,"eighty":-0.918381,"marketCap":244416060},{"date":"2025-02-21","current":-0.923629,"twenty":-13.646228,"median":-9.485831,"eighty":-0.918381,"marketCap":239650287},{"date":"2025-02-28","current":-0.829167,"twenty":-13.53821,"median":-9.464213,"eighty":-0.913133,"marketCap":215140598},{"date":"2025-03-07","current":-0.814527,"twenty":-13.520208,"median":-9.457162,"eighty":-0.907115,"marketCap":245777709},{"date":"2025-03-14","current":-1.077642,"twenty":-13.509406,"median":-9.403571,"eighty":-0.905261,"marketCap":325171057},{"date":"2025-03-21","current":-1.095261,"twenty":-13.498604,"median":-9.381574,"eighty":-0.907115,"marketCap":330487205},{"date":"2025-03-28","current":-1.13637,"twenty":-13.4734,"median":-9.335179,"eighty":-0.907885,"marketCap":342891551},{"date":"2025-04-04","current":-1.030661,"twenty":-13.401388,"median":-9.276768,"eighty":-0.91122,"marketCap":310994662},{"date":"2025-04-11","current":-1.024788,"twenty":-13.390586,"median":-9.158106,"eighty":-0.91122,"marketCap":309222613},{"date":"2025-04-17","current":-1.121688,"twenty":-13.373304,"median":-9.043363,"eighty":-0.91275,"marketCap":338461427},{"date":"2025-04-25","current":-1.53865,"twenty":-13.343059,"median":-8.982159,"eighty":-0.914886,"marketCap":464276932},{"date":"2025-05-02","current":-1.509287,"twenty":-13.325056,"median":-8.72416,"eighty":-0.91567,"marketCap":455416685},{"date":"2025-05-09","current":-1.854176,"twenty":-13.322175,"median":-8.475859,"eighty":-0.917856,"marketCap":405799303},{"date":"2025-05-16","current":-1.841009,"twenty":-13.322175,"median":-8.367278,"eighty":-0.918381,"marketCap":402917713},{"date":"2025-05-23","current":-2.183143,"twenty":-13.319295,"median":-7.903343,"eighty":-0.92048,"marketCap":477796226},{"date":"2025-05-30","current":-1.995784,"twenty":-13.314254,"median":-7.771731,"eighty":-0.922579,"marketCap":436791326},{"date":"2025-06-06","current":-2.05688,"twenty":-13.307052,"median":-7.391851,"eighty":-0.923629,"marketCap":450162489},{"date":"2025-06-13","current":-2.248312,"twenty":-13.28689,"median":-7.071912,"eighty":-0.925203,"marketCap":492058800},{"date":"2025-06-20","current":-2.077245,"twenty":-13.269029,"median":-6.916248,"eighty":-0.926807,"marketCap":454619543},{"date":"2025-06-27","current":-2.647469,"twenty":-13.234175,"median":-6.748144,"eighty":-0.927638,"marketCap":579417065},{"date":"2025-07-03","current":-2.566008,"twenty":-13.195435,"median":-6.610248,"eighty":-0.928935,"marketCap":561588848},{"date":"2025-07-11","current":-3.009968,"twenty":-13.176711,"median":-6.543926,"eighty":-0.934125,"marketCap":658752632},{"date":"2025-07-18","current":-3.372468,"twenty":-13.112621,"median":-6.486852,"eighty":-0.935699,"marketCap":738088200},{"date":"2025-07-25","current":-3.380614,"twenty":-13.094618,"median":-6.275417,"eighty":-0.942521,"marketCap":739871022},{"date":"2025-08-01","current":-3.270642,"twenty":-13.033049,"median":-6.057475,"eighty":-0.94462,"marketCap":715802928},{"date":"2025-08-08","current":-3.725299,"twenty":-13.02693,"median":-5.922572,"eighty":-0.94567,"marketCap":698866122},{"date":"2025-08-15","current":-3.997325,"twenty":-13.019726,"median":-5.435595,"eighty":-0.951442,"marketCap":749898103},{"date":"2025-08-22","current":-4.006831,"twenty":-13.015405,"median":-4.716217,"eighty":-0.959839,"marketCap":751681451},{"date":"2025-08-29","current":-4.477384,"twenty":-12.995573,"median":-4.499689,"eighty":-0.968976,"marketCap":839957209},{"date":"2025-09-05","current":-4.729296,"twenty":-12.985377,"median":-4.583412,"eighty":-0.971934,"marketCap":887215948},{"date":"2025-09-12","current":-6.732102,"twenty":-12.969318,"median":-4.716217,"eighty":-0.972788,"marketCap":1262942394},{"date":"2025-09-19","current":-7.533814,"twenty":-12.962116,"median":-4.795839,"eighty":-0.976108,"marketCap":1413343474},{"date":"2025-09-26","current":-7.85791,"twenty":-12.954915,"median":-4.995468,"eighty":-0.980743,"marketCap":1474143910},{"date":"2025-10-03","current":-7.556557,"twenty":-12.933312,"median":-5.435595,"eighty":-0.981356,"marketCap":1417610171},{"date":"2025-10-10","current":-8.227493,"twenty":-12.912877,"median":-5.922572,"eighty":-0.98398,"marketCap":1543477741},{"date":"2025-10-17","current":-8.625506,"twenty":-12.911708,"median":-6.057475,"eighty":-0.989228,"marketCap":1618144943},{"date":"2025-10-24","current":-8.136519,"twenty":-12.900906,"median":-6.275417,"eighty":-0.991851,"marketCap":1526410951},{"date":"2025-10-31","current":-7.988686,"twenty":-12.843297,"median":-6.486852,"eighty":-0.997099,"marketCap":1498677419},{"date":"2025-11-07","current":-8.903124,"twenty":-12.836096,"median":-6.543926,"eighty":-1.00717,"marketCap":1329076202},{"date":"2025-11-14","current":-9.136795,"twenty":-12.810892,"median":-6.592138,"eighty":-1.007595,"marketCap":1363959046},{"date":"2025-11-21","current":-9.982795,"twenty":-12.807291,"median":-6.666184,"eighty":-1.007595,"marketCap":1490251551},{"date":"2025-11-28","current":-11.020064,"twenty":-12.804411,"median":-6.732102,"eighty":-1.013893,"marketCap":1645097143},{"date":"2025-12-05","current":-10.659594,"twenty":-12.80081,"median":-6.814865,"eighty":-1.015877,"marketCap":1591285554},{"date":"2025-12-12","current":-9.614969,"twenty":-12.80009,"median":-6.916248,"eighty":-1.020831,"marketCap":1435341766},{"date":"2025-12-19","current":-8.768969,"twenty":-12.797636,"median":-7.089499,"eighty":-1.024239,"marketCap":1309049262},{"date":"2025-12-26","current":-9.188291,"twenty":-12.796703,"median":-7.190858,"eighty":-1.024788,"marketCap":1371646416},{"date":"2026-01-02","current":-8.886673,"twenty":-12.786407,"median":-7.397353,"eighty":-1.025258,"marketCap":1326620393},{"date":"2026-01-09","current":-8.702761,"twenty":-12.766964,"median":-7.567929,"eighty":-1.027013,"marketCap":1299165501},{"date":"2026-01-16","current":-9.946012,"twenty":-12.753282,"median":-7.623933,"eighty":-1.029417,"marketCap":1484760572},{"date":"2026-01-23","current":-11.939628,"twenty":-12.741761,"median":-7.664589,"eighty":-1.031296,"marketCap":1782371604},{"date":"2026-01-30","current":-10.924429,"twenty":-12.730234,"median":-7.727134,"eighty":-1.033939,"marketCap":1630820599},{"date":"2026-02-05","current":-10.210847,"twenty":-12.695651,"median":-7.771731,"eighty":-1.034357,"marketCap":1524295617}],"updateTime":1770437086371},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609531895","title":"Amylyx Co-CEO Justin B. Klee Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609531895","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609531895?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:05","pubTimestamp":1770239153,"startTime":"0","endTime":"0","summary":"Justin B. Klee, Co-Chief Executive Officer and Director of Amylyx Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL7tQc29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amylyx Co-CEO Justin B. Klee Reports Sale of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2605121380","title":"Amylyx Co-CEO Joshua B. Cohen Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605121380","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605121380?lang=en_us&edition=fundamental","pubTime":"2026-01-21 10:46","pubTimestamp":1768963613,"startTime":"0","endTime":"0","summary":"Joshua B. Cohen, Co-Chief Executive Officer and Director of Amylyx Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL9kydJp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amylyx Co-CEO Joshua B. Cohen Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2602543356","title":"Amylyx Pharmaceuticals (AMLX) Valuation Check After AMX0318 Rare Disease Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543356","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543356?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:15","pubTimestamp":1768216545,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) drew fresh investor attention after announcing AMX0318, a long-acting GLP-1 receptor antagonist, as a new development candidate for post-bariatric hypoglycemia and other rare diseases.\nSee our latest analysis for Amylyx Pharmaceuticals.\nThe AMX0318 announcement comes after a mixed stretch for the stock, with a 7-day share price return of 7.2% and a 30-day share price decline of 6.8%. The 1-year total shareholder return of about 3x suggests earlier momentum that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-pharmaceuticals-amlx-valuation-check-after-amx0318-ra","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-pharmaceuticals-amlx-valuation-check-after-amx0318-ra","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","AMLX","DCF"],"gpt_icon":0},{"id":"2602131868","title":"Amylyx Co-CEO Justin Klee Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602131868","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602131868?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:05","pubTimestamp":1767906352,"startTime":"0","endTime":"0","summary":"Justin B. Klee, Co-Chief Executive Officer and Director of Amylyx Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3vpTHf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amylyx Co-CEO Justin Klee Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2601536125","title":"Amylyx Pharmaceuticals Nominates AMX0318 as Candidate to Treat Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536125","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536125?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:56","pubTimestamp":1767877007,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals  said Thursday that it has designated AMX0318 as a development candidate for post-bariatric hypoglycemia, and other rare diseases.The company said AMX0318 was selected as part of a research collaboration agreement with Danish preclinical contract research Gubra, which will receive a $4 million milestone payment for the selection.Under the terms of the collaboration, Gubra is eligible to receive more than $50 million in success-based development and commercialization milestones, as well as mid-single digit royalties on global net sales.Shares of Amylyx were up more than 3% pre-bell.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["POST","AMLX","BK4007","BK4212"],"gpt_icon":0},{"id":"2601369626","title":"Amylyx selects AMX0318 as development candidate for PBH","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369626","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369626?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:16","pubTimestamp":1767874607,"startTime":"0","endTime":"0","summary":"Amylyx (AMLX) announced the selection of AMX0318, a long-acting glucagon-like peptide-1 receptor antagonist, as a development candidate for post-ba...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-selects-amx0318-as-development-candidate-for-pbh-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-selects-amx0318-as-development-candidate-for-pbh-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AMLX","PBH"],"gpt_icon":0},{"id":"2601664633","title":"Amylyx Pharmaceuticals Advances AMX0318 as Long-Acting GLP-1 Receptor Antagonist for Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2601664633","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601664633?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873645,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. has announced the nomination of AMX0318 as a novel, long-acting GLP-1 receptor antagonist development candidate, identified in collaboration with Gubra A/S. AMX0318 is being developed for post-bariatric hypoglycemia  and other rare diseases. The candidate has completed extensive preclinical evaluation, demonstrating robust stability, solubility, potency, in vivo pharmacokinetics and pharmacodynamics, and tolerability. Amylyx expects to advance AMX0318 into investigational new drug -enabling studies later this year, with an IND submission targeted for 2027, pending successful study completion. The results have not yet been presented; further development is ongoing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL2M7hcL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2601936619","title":"Amylyx Pharmaceuticals Announces Nomination of Amx0318 as a Novel, Long-Acting Glp-1 Receptor Antagonist Development Candidate, Identified in Collaboration With Gubra a/S","url":"https://stock-news.laohu8.com/highlight/detail?id=2601936619","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601936619?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA67HXV3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2601366146","title":"Amylyx Pharmaceuticals Inc - Gubra to Receive Over $50 Mln in Milestones and Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366146?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA67HXV3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2601003470","title":"Assessing Amylyx Pharmaceuticals (AMLX) Valuation After Insider Buying And AMX0114 Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2601003470","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601003470?lang=en_us&edition=fundamental","pubTime":"2026-01-05 13:22","pubTimestamp":1767590562,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) is back in focus after a director bought more than $100,000 of company stock, alongside encouraging early safety data from its AMX0114 ALS program and an expansion of a related clinical trial.\nSee our latest analysis for Amylyx Pharmaceuticals.\nDespite the director buying and the AMX0114 updates, recent trading has been weak, with a 30 day share price return of a 19.58% decline and a 90 day return of a 15.34% decline, while the 1 year total shareholder return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/assessing-amylyx-pharmaceuticals-amlx-valuation-after-inside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/assessing-amylyx-pharmaceuticals-amlx-valuation-after-inside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU2065732104.USD","BK4097","BK4007","PRGS","AMLX"],"gpt_icon":0},{"id":"2593447118","title":"Director Karen Firestone Acquires Common Shares of Amylyx Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447118","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593447118?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:49","pubTimestamp":1766540956,"startTime":"0","endTime":"0","summary":"Karen Firestone, Director, reported the acquisition of common shares of Amylyx Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nNDL9b1Bgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Karen Firestone Acquires Common Shares of Amylyx Pharmaceuticals Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2590376183","title":"Is Amylyx Pharmaceuticals (AMLX) Overvalued After Its 250% Year‑to‑Date Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590376183","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590376183?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:15","pubTimestamp":1765314907,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) has quietly staged a sharp rebound this year, with the stock up roughly 250% year to date and about 180% over the past year, drawing fresh attention from biotech investors.\nSee our latest analysis for Amylyx Pharmaceuticals.\nThe recent pullback, with a 1 day share price return of minus 3.7 percent and a 7 day share price return of minus 4.0 percent, looks more like a pause in what has been strong upward momentum, given the 30 day share price return of 11.1...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/is-amylyx-pharmaceuticals-amlx-overvalued-after-its-250-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/is-amylyx-pharmaceuticals-amlx-overvalued-after-its-250-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2589781231","title":"BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2589781231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589781231?lang=en_us&edition=fundamental","pubTime":"2025-12-06 03:14","pubTimestamp":1764962096,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Omnicom, Albemarle, energy companiesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL6N3XB0IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PKG","LU0128525689.USD","TE","WBD","AES","SCCO","CHPT","ROL","FANG","HUM","INTS","CDE","LU0128525929.USD","ITT","HL","ULTA","S","XOM","EUDA","COO","AUB","DELL","HPE","ALB","LUV","AMLX","PRAX","PSN","TRMB","ZUMZ","LU0320765646.SGD","RBRK","LU1150488218.USD","TARA","TTAN","IOT","FSLY","DBRG","EQT","VSCO","FCX","OMC","EXE","BMEA"],"gpt_icon":1},{"id":"2589818089","title":"BUZZ-Amylyx rises after promising early-stage trial for ALS drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818089","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589818089?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:21","pubTimestamp":1764944492,"startTime":"0","endTime":"0","summary":"BUZZ-Amylyx rises after promising early-stage trial for ALS drug** Shares of drugmaker Amylyx Pharmaceuticals AMLX.O rise 1.8% to $14.75 premarket** Co says experimental drug, AMX0114, was generally well-tolerated by first group of patients in early-stage trial for amyotrophic lateral sclerosis, or ALS** ALS is a fatal condition that causes progressive muscle weakness and loss of movement, says co** Early-stage trial enrolled 12 patients, with no serious side effects linked to treatment - AMLX** Drug is injected into spinal fluid every four weeks; aims to protect nerve cells, co says** Second group enrollment to start in Canada this month and in January in the U.S. - AMLX** As of last close, stock up ~283% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL4N3XB145:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2589818522","title":"BRIEF-Amylyx Pharmaceuticals Announces New Safety And Tolerability Cohort 1 Data Of Amx0114","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818522","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589818522?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:01","pubTimestamp":1764943311,"startTime":"0","endTime":"0","summary":"BRIEF-Amylyx Pharmaceuticals Announces New Safety And Tolerability Cohort 1 Data Of Amx0114 Dec 5 (Reuters) - Amylyx Pharmaceuticals Inc AMLX.O:AMYLYX PHARMACEUTICALS ANNOUNCES NEW SAFETY AND TOLERABI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUA3HTJKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2589818532","title":"Amylyx Reports Positive Early Safety Data for AMX0114 in ALS Phase 1 LUMINA Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589818532?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:00","pubTimestamp":1764943245,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc. announced early safety and tolerability data from its Phase 1 LUMINA trial of AMX0114, an investigational antisense oligonucleotide targeting calpain-2, in people with amyotrophic lateral sclerosis . The data from the first cohort  were presented at the 36th International Symposium on ALS/MND held December 5-7, 2025, in San Diego, California. According to the company, AMX0114 was generally well-tolerated, with no treatment-related serious adverse events reported. Based on these findings, enrollment for the second cohort is expected to begin in Canada later this month and in the U.S. in January. Amylyx plans to present biomarker data from the first cohort in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL1Tbk9C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2589818591","title":"Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of Amx0114 in ALS From First-in-Human Lumina Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589818591?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:00","pubTimestamp":1764943202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUA3HTJKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2589818516","title":"Amylyx Pharmaceuticals Inc - Amx0114 Well-Tolerated With No Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589818516?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:00","pubTimestamp":1764943202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nTUA3HTJKX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2588024054","title":"Amylyx Pharmaceuticals Chief Medical Officer Camille L. Bedrosian Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588024054","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588024054?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:40","pubTimestamp":1764798027,"startTime":"0","endTime":"0","summary":"Camille L. Bedrosian, Chief Medical Officer of Amylyx Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLbrrlfj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Amylyx Pharmaceuticals Chief Medical Officer Camille L. Bedrosian Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2584926436","title":"Amylyx Pharmaceuticals Q3 EPS USD -0.37 Vs. IBES Estimate USD -0.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2584926436","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584926436?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:52","pubTimestamp":1763571155,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Amylyx Pharmaceuticals Q3 operating income USD -36.027 million vs. IBES estimate USD -43.1 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202511:00:00.293 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD2fmpBP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}